North Macedonia vs Timor-Leste: Immunization, measles
North Macedonia
73.0%
in 2024
Timor-Leste
72.0%
in 2024
North Macedonia rank
159th
Timor-Leste rank
161st
Immunization, measles over time
- North Macedonia
- Timor-Leste
How they compare
North Macedonia currently reports 73.0% against 72.0% in Timor-Leste, a difference of 1.0%.
The two have swapped places 2 times across 23 shared years of data; in 2002 it was North Macedonia ahead.
North Macedonia ranks 159th and Timor-Leste ranks 161st of 193 countries.
Across the 3 decades both report, North Macedonia averaged higher in 2 and Timor-Leste in 1.
Head to head by decade
| Decade | North Macedonia | Timor-Leste | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 96.2% | 60.1% | 36.1% | North Macedonia |
| 2010s | 88.4% | 71.7% | 16.7% | North Macedonia |
| 2020s | 70.0% | 72.4% | 2.4% | Timor-Leste |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, measles, North Macedonia or Timor-Leste?
- North Macedonia, at 73.0% against 72.0% in Timor-Leste as of 2024.
- What is the difference in immunization, measles between North Macedonia and Timor-Leste?
- 1.0%, with North Macedonia ahead.
- How many years of comparable data are there for North Macedonia and Timor-Leste?
- 23 years are reported by both, from 2002 to 2024.
- How do North Macedonia and Timor-Leste rank globally for immunization, measles?
- North Macedonia ranks 159th and Timor-Leste ranks 161st of 193 countries.
- Where does this data come from?
- World Health Organization (WHO), published as Immunization, measles (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, measles, measures the percentage of children ages 12-23 months who received the measles vaccination before 12 months or at any time before the survey. A child is considered adequately immunized against measles after receiving one dose of vaccine.